Left Ventricular Myocardial Work to Differentiate Cardiac Amyloidosis From Hypertrophic Cardiomyopathy - 02/02/23
Doi : 10.1016/j.echo.2022.08.015
Jan Stassen, MD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Department of Cardiology, Jessa Hospital, Hasselt, Belgium
Catherina Tjahjadi, MD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Robert Adam, MD
Department of Cardiology, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Bogdan A. Popescu, MD, PhD
Department of Cardiology, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Ruxandra Jurcut, MD, PhD
Department of Cardiology, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Victoria Delgado, MD, PhD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Jeroen J. Bax, MD, PhD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Nina Ajmone Marsan, MD, PhD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
| Drs. Stassen and Tjahjadi contributed equally to this work. |
|
| Conflicts of Interest: The Department of Cardiology, Heart Lung Center, Leiden University Medical Centre, received research grants from Alnylam, Abbott Vascular, Bayer, Biotronik, Bioventrix, Boston Scientific, Edwards Lifesciences, GE Healthcare, Ionis, and Medtronic. J.J.B. received speaker fees from Abbott Vascular. N.A.M. received speaker fees from Abbott Vascular and GE Healthcare and has been on the Medical Advisory Board of Philips Ultrasound. V.D. received speaker fees from Abbott Vascular, Edwards Lifesciences, GE Healthcare, Medtronic, MSD, and Novartis. J.S. received speaker fees from Pfizer. P.D. received speaker fees from Pfizer and has been involved on the Pfizer Medical Advisory Board. The remaining authors have nothing to disclose. |
|
| J.S. received funding from the European Society of Cardiology (ESC Training Grant App000064741). R.A. and R.J. received funding from an unrestricted educational work grant from the Pfizer competitive grant program under grant contract no. 2480/14.05.2020. |
|
| James D. Thomas, MD, FASE, served as guest editor for this report. |
© 2022
American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 36 - N° 2
P. 252-254 - février 2023 Retour au numéro
Article précédent
- Ventricular Flow Profile in Young Patients With Single Left Ventricle Fontan Using Echocardiographic Contrast Particle Imaging Velocimetry
- Ling Li, Vivek Jani, Mary Craft, Joan Olson, Andreas Schuster, Gianni Pedrizzetti, David Danford, Shelby Kutty
- Relative Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: An Intervendor Software Variability Assessment
- Michael N. Jiang, Julia Simkowski, Nadia El Hangouche, Jeesoo Lee, Milica Marion, Inga Vaitenas, James D. Thomas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?